Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217672
Status:
COMPLETED
Last Update Posted:
2020-08-05
First Post:
2005-09-20
Brief Title:
Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International